Flatiron Health

company

About

Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient.

  • 1001 - 5000

Details

Last Funding Type
Series C
Last Funding Money Raised
$175M
Industries
Biotechnology,Cloud Computing,Electronic Health Record (EHR),Health Care,Health Diagnostics,Hospital,Personal Health
Founded date
Jun 1, 2012
Number Of Employee
1001 - 5000
Operating Status
Active

Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. The company's platform enables cancer researchers and care providers to learn from the experience of every patient. Its database platform aggregates and transforms clinical and financial data from electronic medical records (EMRs) and billing systems that provide comprehensive support to the cancer care providers and life science companies.

Currently, Flatiron partners with over 280 community cancer practices, seven major academic research centers, and over 15 of the top therapeutic oncology companies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$313M
Flatiron Health has raised a total of $313M in funding over 2 rounds. Their latest funding was raised on Jan 6, 2016 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 6, 2016 Series C $175M 2 Roche Detail
May 7, 2014 Series B $130M 1 Detail
Jan 15, 2013 Series A $8M 1 Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Flatiron Health has made 2 investments. Their most recent investment was on Jun 2, 2020, when Play One Up raised $3.10M.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 2, 2020 Play One Up
Seed $3.10M eSports
Jun 5, 2019 Carbon Health
Series B $35M Electronic Health Record (EHR)

Investors

Number of Lead Investors
Number of Investors
1
3
Flatiron Health is funded by 3 investors. Roche and Allen & Company are the most recent investors.
Investor Name Lead Investor Funding Round
Roche Yes Series C
Allen & Company Series C
LabCorp Series B